Furthermore, the compound inhibits cancer cell metastasis by suppressing matrix metalloproteinase‐2 (MMP‐2) and MMP‐9 expression through the inhibition of NF‐κB and AP‐1 signaling [112] as shown in Figure 4. Here, NFKB1 is linked to cancer.